Persistence of antibody responses to Haemophilus influenzae type b polysaccharide conjugate vaccine in children with vertically acquired human immunodeficiency virus infection

Pediatric Infectious Disease Journal

Volumn 15, Issue 12, 1996, Pages 1097-1101

  Gibb, Diana ^a,e   Giacomelli, Antonio ^d   Masters, Janet ^a   Spoulou, Vana ^a   Ruga, Ezia ^d   Griffiths, Helen ^b   Kroll, Simon ^c   Giaquinto, Carlo ^d   Goldblatt, David ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

^d Department of Pediatrics ^*

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

antibodies; Haemophilus influenzae type b; human immunodeficiency virus; IgG

Indexed keywords

CD4 ANTIGEN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; CHILD; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; IMMUNOPROPHYLAXIS; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VERTICAL TRANSMISSION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBODIES, BACTERIAL; BACTEREMIA; DISEASE TRANSMISSION, VERTICAL; FEMALE; FOLLOW-UP STUDIES; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION, SECONDARY; INFANT; MALE; POLYSACCHARIDES, BACTERIAL; REFERENCE VALUES;

EID: 0030443960     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199612000-00008     Document Type: Article

References (13)

1. Gibb D, Spoulou V, Giacomelli A, et al. Antibody responses to Haemophilus influenzae type b and Streptococcus pneumoniae vaccines in children with human immunodeficiency virus infection. Pediatr Infect Dis J 1995;14:129-35.
2. Booy R, Taylor SA, Dobson SRM, et al. Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunization schedule. Arch Dis Child 1992;67:475-8.
3. Wade AM, Ades AE. Age-related reference ranges: significance tests for models and confidence intervals for centiles. Stat Med 1994;13:2359-67.
4. Al-Attar I, Reisman J, Muehlmann M, McIntosh K. Decline of measles antibody titers after immunization in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1994;14:149-50.
5. Claesson BA, Schneerson R, Lagergard T, et al. Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of age. Pediatr Infect Dis J 1991;10:560-4.
6. Mulholland EK, Todd J, Rowe M, et al. Persistence of antibody at 18 months following vaccination of young Gambian infants with PRP-OMPC Haemophilus influenzae type b conjugate vaccine. Ann Trop Paediatr 1993;13:153-8.
7. Berkowitz CD, Ward JI, Chiu CE, et al. Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age. Pediatrics 1990;85:288-93.
8. Rothstein EP, Madore DV, Long SS. Antibody persistence four years after primary immunization of infants and toddlers with Haemophilus influenzae type b CRM197 conjugate vaccine. J Pediatr 1991;119:655-7.
9. Walter EB, Simmons SS, Clements DA. Anti-polyribosylribitol phosphate antibody levels 5 years after a primary series of Haemophilus influenzae type b conjugate vaccine [Letter], J Infect Dis 1994;170:1050-1.
10. Peters VB, Sunil KS. Immunity to Haemophilus influenzae type b polysaccharide capsule in children with human immunodeficiency virus infection immunized with a single dose of Haemophilus vaccine. J Pediatr 1994;125:74-7.
11. Kurikka S, Käyhty H, Saarinen L, Ronnberg PR, Eskola J, Mäkelä PH. Immunologic priming by one dose of Haemophilus influenzae type b conjugate vaccine in infancy. J Infect Dis 1995;172:1268-72.
12. Peltola H, Käyhty H, Sivonen A, Mäkelä PH. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100 000 vaccinees 3 months to 5 years of age in Finland. Pediatrics 1977;60:730-7.
13. Borkowsky W, Moore T, Krasinski K, Ajuang-Simbiri KO, Holzman R. Evolution of phenotypic memory T cells in HIV-1 infected infants and children. Clin Immunol Immunopathol 1992;63:280-84.